Axcelis Technologies Inc (ACLS) is not a strong buy at this moment for a beginner investor with a long-term focus. While the stock has shown a recent price increase, the lack of clear positive catalysts, declining financial performance, and neutral technical indicators suggest that waiting for a more favorable entry point or clearer signs of recovery would be prudent.

Technical Analysis

The MACD histogram is negative (-0.774) and contracting, RSI is neutral at 48.964, and moving averages are converging, indicating no clear trend. The stock is trading below the pivot level (86.491) with key support at 77.4 and resistance at 95.583.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment in the options market, but the overall trading volume is low, limiting its significance.

Technical Summary

Sell

Buy

Positive Catalysts

Gross margin increased by 2.02% YoY in Q4 2025, indicating some operational efficiency improvement. The options market sentiment is mildly bullish.

Neutral/Negative Catalysts

Analysts have lowered price targets and maintain neutral or underperform ratings due to softer guidance and flattish revenue outlook. No recent news or significant insider/hedge fund activity to drive momentum.

Financial Performance

In Q4 2025, revenue dropped by 5.58% YoY, net income declined by 31.35% YoY, and EPS fell by 28.57% YoY. While gross margin improved slightly to 46.97%, the overall financial performance was weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have recently lowered price targets (e.g., B. Riley to $91 from $94, BofA to $90 from $100) and maintain neutral or underperform ratings. Concerns include softer guidance, flattish revenue outlook, and risks related to China market exposure.

3 Analyst Rating

Wall Street analysts forecast ACLS stock price to rise

1 Buy

1 Hold

1 Sell

Hold

Current: 82.610

Low

Averages

99.67

High

105

Current: 82.610

Low

Averages

99.67

High

105

B. Riley

Neutral

downgrade

$94 -> $91

AI Analysis

2026-02-18

Reason

B. Riley

Price Target

$94 -> $91

AI Analysis

2026-02-18

downgrade

Neutral

Reason

B. Riley lowered the firm's price target on Axcelis to $91 from $94 and keeps a Neutral rating on the shares. Axcelis delivered a strong Q4 beat driven by Services and Systems upside and still-elevated China exposure, but softer 1Q26 guidance and flattish CY26 revenue outlook, due to Mature Foundry digestion offsetting Memory gains, pressured shares, the analyst tells investors in a research note. While near-term gross margin compression appears mix-driven rather than structural, moderating expectations and a growing Memory contribution suggest improving 2H26 momentum despite guidance modestly below consensus, the firm says.

BofA

Duksan Jang

Underperform

downgrade

$100 -> $90

2026-02-18

Reason

BofA

Duksan Jang

Price Target

$100 -> $90

2026-02-18

downgrade

Underperform

Reason

BofA analyst Duksan Jang lowered the firm's price target on Axcelis to $90 from $100 and keeps an Underperform rating on the shares. The firm, which is waiting for clearer signs of recovery, lowered its calendar year 2026-28 sales estimates by 5%-8% and EPS estimates by 9%-16%.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ACLS

Unlock Now

ACLS Should I Buy

ACLS Should I Buy

Should You Buy Axcelis Technologies Inc (ACLS) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch